Monotherapy: Clinical Trials

2 trials for Monotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Monotherapy: new trials by email Literature Review of Monotherapy trials Research Report on Monotherapy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older
Lacosamide, Carbamazepine-Controlled Release (CBZ-CR) - Epilepsy, Monotherapy
Phase 3CompletedUCB BIOSCIENCES GmbH5512012-05-012018-07-18
Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older
Lacosamide, Carbamazepine-Controlled Release - Epilepsy, Monotherapy
Phase 3CompletedUCB BIOSCIENCES GmbH8882011-04-012021-02-02

Narrower conditions

Epilepsy (2)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)

Interventions

Lacosamide (2)

Sponsors

UCB BIOSCIENCES GmbH (2)

Countries

Australia (2)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Czechia (2)  ·  Finland (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Hungary (2)  ·  Italy (2)  ·  Japan (2)  ·  Latvia (2)  ·  Lithuania (2)  ·  Mexico (2)

Results publications

PMID 27889312, PMID 28290119, PMID 33200428, PMID 34265173